Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform [Yahoo! Finance]
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $170.00 price target on the stock, down previously from $19
3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]